Timothy James Rink

Timothy James Rink

Direktör/Styrelseledamot på
Kymab Ltd.
80 år
Health Technology
Electronic Technology
Commercial Services

Profil

Timothy James Rink is a former Chairman, President & CEO of Aurora Biosciences Corp.
He was also the Chairman-Technology Transfer Division of The Wellcome Trust Ltd. He is currently a Non-Executive Director at Kymab Ltd. and a Director at Kymab Group Ltd. In addition, he has held various director positions at several companies including Sumitomo Pharma America, Inc., NPS Pharmaceuticals, Inc., Alanex Corp., Akubio Ltd., Lorantis Ltd., Astex Therapeutics Ltd., Gryphon Therapeutics, Inc., BioVex Ltd., Adnexus, Solexa Ltd., Ciphergen Biosystems KK, Santhera Pharmaceuticals Holding AG, and Stevenage Bioscience Catalyst.
Rink has also served as a Member-Scientific Advisory Board at Serono SA. Rink holds a graduate and doctorate degree from the University of Cambridge.

Aktiva positioner av Timothy James Rink

FöretagPositionStart
Direktör/Styrelseledamot -
Direktör/Styrelseledamot 2016-11-23

Tidigare kända positioner av Timothy James Rink

FöretagPositionSlut
Ordförande 2022-07-18
SANTHERA PHARMACEUTICALS HOLDING AG Direktör/Styrelseledamot -
Företagsledare/Principal 2010-01-01
Direktör/Styrelseledamot 2009-10-20
Direktör/Styrelseledamot 2005-10-01
Se detaljerna i Timothy James Rinks erfarenhet

Timothy James Rinks utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

68

Första gradens relationer

23

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag23

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Miscellaneous

Health Technology

Electronic Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Electronic Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

  1. Börsen
  2. Insiders
  3. Timothy James Rink